ONESOURCE / NSE / Biotechnology & Drugs
Onesource Specialty Pharma
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High2,249.65
Target Low1,075
Target Mean1.25
Target Median31.25
Risk Metrics
Overall RiskHigh risk
Board Risk57.98
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Compare with Equitymaster
OneSource Specialty Pharma: Capacity Expansion Sets Stage for FY27-28 Growth Target Moneylife
Onesource Specialty Pharma - Negative Breakout: These 9 stocks drop below their 200 DMAs The Economic Times
OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
OneSource Specialty Pharma Ltd is Rated Sell Markets Mojo
OneSource Specialty Pharma Downgraded to Sell Amid Weak Financials and Technical Signals Markets Mojo
Why the Brooks Steriscience–OneSource deal was called off Moneycontrol.com
OneSource Specialty Pharma Ltd Technical Momentum Shifts Amid Mixed Signals Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

